Chitosan-sodium alginate blended polyelectrolyte complexes as potential multiparticulate carrier system: Colon-targeted delivery and gamma scintigraphic imaging

Expert Opinion on Drug Delivery

Volumn 10, Issue 1, 2013, Pages 5-15

  Lanjhiyana, Sanjay K ^a   Bajpayee, Pranav ^a   Kesavan, Karthikeyan ^a   Lanjhiyana, Sweety ^b   Muthu, Madaswamy S ^c  

^a GURU GHASIDAS UNIVERSITY   (India)

^b Chouksey College of Engineering   (India)

^c BANARAS HINDU UNIVERSITY   (India)

Author keywords

Biodegradability; Chitosan; Dual ionic gelation method; In vivo targeting; Multiparticulate system; Sodium alginate; Tinidazole

Indexed keywords

ALGINIC ACID; CALCIUM CHLORIDE; CHITOSAN; POLYELECTROLYTE; SODIUM SULFATE; TINIDAZOLE;

AMEBIASIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIODEGRADABILITY; CROSS LINKING; DRUG DELIVERY SYSTEM; GAMMA SCINTIGRAPHY; GELATION; IN VITRO STUDY; IN VIVO STUDY; MALE; MECHANICAL TORSION; NONHUMAN; PARTICLE SIZE; RAT; SUSTAINED DRUG RELEASE;

ALGINATES; ANIMALS; ANTITRICHOMONAL AGENTS; CHEMISTRY, PHARMACEUTICAL; CHITOSAN; COLON; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; GLUCURONIC ACID; HEXURONIC ACIDS; MALE; MICROSPHERES; ORGANOTECHNETIUM COMPOUNDS; PARTICLE SIZE; RADIONUCLIDE IMAGING; RADIOPHARMACEUTICALS; RATS; TINIDAZOLE;

EID: 84871430171     PISSN: 17425247     EISSN: 17447593     Source Type: Journal    
DOI: 10.1517/17425247.2013.734805     Document Type: Article

References (51)

1. Gregoriadis G, Florence AT. Liposome in drug delivery. Clinical, diagnostic and ophthalmic potential. Drugs 1993;45:15-28 (Pubitemid 23093890)
2. Zhang H, Alsarra IA, Neau SH. An in vitro evaluation of a chitosan-containing multi-particulate system for macromolecule delivery to the colon. Int J Pharm 2002;239:197-205 (Pubitemid 34615809)
3. Shu XZ, Zhu KJ. The release behavior of brilliant blue from calcium- alginate gel beads coated by chitosan: the preparation method effect. Eur J Pharm Biopharm 2002;53:193-201 (Pubitemid 34189794)
4. Wang J, Kaplan DL, Wiley BJ, et al. Mucoadhesive properties of aminated gelation microcapsules. Biomed Polymers 1994;67:189-212
5. Hejazi R, Gompotz WR, Wee SF. Prepration and characterization of tetracycline loaded chitosan microcapsules. Adv Drug Del Rev 1998;81:267-85
6. Illum L. Chitosan and its use as pharmaceutical excipients. Pharm Res 1998;15:1326-31 (Pubitemid 28427917)
7. Furda I. Aminopolysaccharides-their potential as dietary fiber. Unconventional sources of dietary fiber, Physiological and in vitro functional properties. American Chemical Society; Washington, DC: 1983
8. Ormrod DJ, Holmes CC, Miller TE. Dietary chitosan inhibits hypercholesterolaemia and atherogenesis in the apolipoprotein E-deficient mouse model of atherosclerosis. Atherosclerosis 1998;138:329-34 (Pubitemid 28313517)
9. Filion D, Lavertu M, Buschmann MD. Ionization and solubility of chitosan solutions related to thermosensitive chitosan/glycerol-phosphate systems. Biomacromolecules 2007;8:3224-34 (Pubitemid 350011646)
10. Sabins S, Block LH. Chitosan as an enabling excipient for drug delivery systems I. Molecular modifications. Int J Biol Macromol 2000;27:181-6 (Pubitemid 30316288)
11. Zhang H, Neau SH. In vitro degradation of chitosan by bacterial enzymes from rat cecal and colonic contents. Biomaterials 2002;23:2761-6 (Pubitemid 34465735)
12. Yamamoto A, Tozaki H, Okada N, et al. Colon specific delivery of peptide drugs and anti-inflammatory drugs using chitosan capsules. STP Pharm Sci 2000;10:23-43
13. Tozaki H, Odoriba T, Okada N, et al. Chitosan capsules for colon-specific drug delivery: enhanced localization of 5-aminosalicylic acid in the large intestine accelerates healing of TNBS-induced colitis in rats. J Control Release 2002;82:51-61 (Pubitemid 34775047)
14. Fernandez-Hervas MJ, Fell JT. Pectin/ chitosan mixtures as coatings for colon-specific drug delivery: an in vitro evaluation. Int J Pharm 1998;169:115-19 (Pubitemid 28352604)
15. Draget KI. Alginates. In: Philips GO, Williams PA, editiors Handbook of hydrocolloids. Woodhead Publishing; Cambridge: 2000
16. Liu HX, Wang CY, Gao QX, et al. Fabrication of novel core-shell hybrid alginate hydrogel beads. Int J Pharm 2008;351:104-12
17. Tomme SRV, Storm G, Hennink WE. In situ gelling hydrogels for pharmaceutical and biomedical applications. Int J Pharm 2008;355:1-18
18. Ostberg T, Lund EM, Graffner C. Calcium alginate matrices for oral multiple unit administration. IV. Release characteristics in different media. Int J Pharm 1994;112:241-8
19. Sugawara S, Imai T, Otagiri M. The controlled release of prednisolone using alginate gel. Pharm Res 1994;11:272-7 (Pubitemid 24076223)
20. Pasparakis G, Bouropoulos N. Swelling studies and in vitro release of verapamil from calcium alginate and calcium alginate-chitosan beads. Int J Pharm 2006;323:34-42 (Pubitemid 44397368)
21. Sriamornsak P, Kennedy AR. A novel gel formation method, microstructure and mechanical properties of calcium polysaccharide gel films. Int J Pharm 2006;323:72-80 (Pubitemid 44397360)
22. Pongjanyakul T, Puttipipatkhachorn S. Xanthan-alginate composite gel beads: molecular interaction and in vitro characterization. Int J Pharm 2007;331:61-71 (Pubitemid 46176497)
23. Yotsuyanaqi T. Effect of cholesterol on liposome stability to ultrasonic disintegration and sodium cholate solubilizationet. Chem Pharm Bull 1987;35:1228-33
24. Hwang SJ, Rhee GJ, Lee KM, et al. Release characteristics of ibuprofen from excipient-loaded alginate gel beads. Int J Pharm 1995;116:125-8
25. Fernandez-Hervas MJ, Holgado MA, Fini A, et al. In vitro evaluation of alginate beads of a diclofenac salt. Int J Pharm 1998;163:23-34 (Pubitemid 28162617)
26. Grant GT, Morris ER, Rees DA, et al. Biological interaction between polysaccharides and divalent cations: the egg-box model. FEBS Lett 1973;32:195-8
27. Rees DA, Welsh EJ. Secondary and tertiary structure of poysaccharides in solutions and gels. Angew Chem Int Edit Engl 1977;16:214-24
28. Gotoh T, Matsushima K, Kiduchi KI. Preparation of alginate-chitosan hybrid gel beads and adsorption of divalent metal ions. Chemosphere 2004;55:135-40 (Pubitemid 38147851)
29. Hein S, Wang K, Stevens WF, et al. Chitosan composites for biomedical applications: status, challenges and perspectives. Mater Sci Technol 2008;24:1053-61
30. Nakajima A, Shimoda K. Complex formation between oppositely charged polysaccharides. J Colloid Interface Sci 1976;55:126-32
31. Xu Y, Zhan C, Fan L, et al. Preparation of dual crosslinked alginate-chitosan blend gel beads and in vitro controlled release in oral site specific drug delivery system. Int J Pharm Sci 2007;336:329-37 (Pubitemid 46670661)
32. Babister JC, Tare RS, Green DW, et al. Genetic manipulation of human mesenchymal progenitors to promote chondrogenesis using "bead-in-bead" polysaccharide capsules. Biomaterials 2008;29:58-65 (Pubitemid 47610692)
33. Lai HL, Abu Khalil A, Craig DQM. The preparation and characterization of drug-loaded alginate and chitosan sponges. Int J Pharm 2003;251:175-81 (Pubitemid 36071472)
34. Li ZS, Ramay HR, Hauch K.D, et al. Chitosan-alginate hybrid scaffolds for bone tissue engineering. Biomaterials 2005;26:3919-28 (Pubitemid 40038783)
35. Bodmeier R, Paeratakul O. Suspensions and dispersible dosage forms of multiparticulates. In: Ghebre-Sellassie I, editor. Multiparticulate oral drug delivery. Marcel Dekker; New York 1994:143-156
36. Meyer JH, Dressman J, Fink AS, Amidon G. Effect of size and density oncanine gastric emptying of nondigestible solids. Gastroenterology 1985;89:805-13 (Pubitemid 15015296)
37. Davis SS. Assessment of gastrointestinal transit and drug absorption. In: Prescott LF, Nimmo WS, editors. Novel drug delivery and its therapeutic application. Wiley; Chichester, UK 1990:89-101
38. Swords R, Cantey RJ. Amoebiasis. Gastroent clin 2002;25:28-9
39. Stanley SL Jr. Amoebiasis. Lancet 2003;361:1025-34
40. Joseph T, Venkatraman V, Nagarani A, et al. Safety pharmacology of a combination of tinidazole and oxyphenonium bromide. Arzneimittelforschung 1997;47:869-72 (Pubitemid 27319892)
41. Xu Y, Zhan C, Fan L, et al. Preparation of dual crosslinked alginate-chitosan blend gel beads and in vitro controlled release in oral site-specific drug delivery system. Int J Pharm 2007;336:329-37 (Pubitemid 46670661)
42. Sinha VR, Singh A, Singh S, Bhinge Jr. Compression coated systems for colonic delivery of 5-fluorouracil. J Pharm Pharmacol 2007;59:359-65 (Pubitemid 47050899)
43. VandenMooter G, Samyn C, Kinget R. Azo polymers for colon-specific drug delivery. II: influence of the type of azo polymer on the degradation by intestinal microflora. Int J Pharm 1993;97:133-9 (Pubitemid 23242374)
44. Gibaldi M, Feldman S. Establishment of sink conditions in dissolution rate determinations. Theoretical considerations and application to non-disintegrating dosage forms. J Pharm Sci 1967;56:1238-42
45. Wagner JG. Interpretation of percent dissolved-time plots derived from in vitro testing of conventional tablets and capsules. J Pharm Sci 1969;58:1253-7
46. Higuchi T. Mechanism of sustained action medication: theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci 1963;52:1145-9
47. Korsmeyer RW, Gurny R, Doelker EM. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm 1983;15:25-35 (Pubitemid 13092121)
48. Peppas NA. Analysis of Fickian and non-Fickian drug release polymers. Pharm Acta Helv 1985;60:110-11
49. Lai H, Zhu F, Yuan W, et al. Development of multi-unit colon targeted drug delivery system by using alginate: in vitro and in vivo evaluation. Drug Dev Ind Pharm 2011;37:1347-56
50. Srinatha A, Pandit JK, Singh S. Ionic cross-linked chitosan beads for extended release of ciprofloxacin: in vitro charecterization. Indian J Pharm Sci 2008;70:16-21 (Pubitemid 351670563)
51. Sinha VR, Mittal BR, Bhutani KK, Kumaria R. Colonic drug delivery of 5- fluorouracil: an in vitro evaluation. Int J Pharm 2004;269:101-8H